That's what The Atlantic said about too-close corporate contracting in academic research four years ago. Now a deal at the center of the criticism, UC-Berkeley's medical research contract with Novartis, is about to get a nearly clean bill of health from an independent review panel.
So is this kind of close collaboration with big companies what Clark Kerr's generation had in mind for the "Multiversity" as member of the military-industrial complex? How close is too close? And how much private profit is too much?
Posted by Martha Bridegam at July 31, 2004 02:08 PM